General Information of MET (ID: META00859)
Name Sphingomyelin (d18:0/16:0)
Synonyms   Click to Show/Hide Synonyms of This Metabolite
(2S,3R)-3-Hydroxy-2-(palmitoylamino)octadecyl 2-(trimethylazaniumyl)ethyl phosphate; (2S,3R)-3-Hydroxy-2-(palmitoylamino)octadecyl 2-(trimethylazaniumyl)ethyl phosphoric acid; 16:0 Dihydrosphingomyelin; C16 Dihydrosphingomyelin; C16-Dihydrosphingomyelin; Dihydrosphingomyelin C16:0; N-(Hexadecanoyl)-1-phosphocholine-D-erythro-sphinganine; N-(Hexadecanoyl)-1-phosphocholine-dihydrosphingosine; N-(Hexadecanoyl)-1-phosphocholine-sphinganine; N-(Hexadecanoyl)-sphinganine-1-phosphocholine; N-Hexadecanoyl-sphinganine-1-phosphocholine; N-Hexadecanoyldihydroceramide-1-phosphocholine; N-Palmitoyldihydroceramide-1-phosphocholine; N-Palmitoyldihydrosphingomyelin; N-Palmitoylsphinganine-1-phosphocholine; Palmitoyl dihydrosphingomyelin; Palmitoyl dihydrosphingomyelin (d18:0/16:0); Palmitoyldihydrosphingomyelin; SM d18:0/16:0; SM(18:0/16:0); SM(d18:0/16:0); Sphingomyelin; Sphingomyelin (d18:0,C16:0); Sphingomyelin (d18:0/16:0); Sphingomyelin(d18:0/16:0); {[(2S,3R)-2-hexadecanamido-3-hydroxyoctadecyl]oxy}[2-(trimethylazaniumyl)ethoxy]phosphinate; {[(2S,3R)-2-hexadecanamido-3-hydroxyoctadecyl]oxy}[2-(trimethylazaniumyl)ethoxy]phosphinic acid
Source Aliphatic acyclic compounds
Structure Type   Phosphosphingolipids  (Click to Show/Hide the Complete Structure Type Hierarchy)
Lipids and lipid-like molecules
Sphingolipids
Phosphosphingolipids
PubChem CID
9939965
HMDB ID
HMDB0010168
Formula
C39H81N2O6P
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=9939965"></iframe>
3D MOL is unavailable 2D MOL
  Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
ChEBI ID
78647
FooDB ID
FDB027351
ChemSpider ID
8115586
Physicochemical Properties Molecular Weight 705 Topological Polar Surface Area 108
XlogP 12.8 Complexity 755
Heavy Atom Count 48 Rotatable Bond Count 37
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
Function
Sphingomyelin (d18:0/16:0) or SM(d18:0/16:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(d18:0/16:0) consists of a sphinganine backbone and a palmitic acid chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.
Regulatory Network
Full List of Protein(s) Regulating This Metabolite
      Pore-forming PNC peptide (PNC)
            Cellular tumor antigen p53 (TP53) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [1]
                      Introduced Variation Knockout of TP53
                      Induced Change Sphingomyelin (d18:0/16:0) concentration: decrease (Log2 FC=0.93)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Colon cancer [ICD-11: 2B90]
                      Details It is reported that knockout of TP53 leads to the decrease of sphingomyelin (d18:0/16:0) levels compared with control group.
      Transferases (EC 2)
            Arylamine N-acetyltransferase 1 (NAT1) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [2]
                      Introduced Variation Knockout of NAT1
                      Induced Change Sphingomyelin (d18:0/16:0) concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Breast cancer [ICD-11: 2C60]
                      Details It is reported that knockout of NAT1 leads to the decrease of sphingomyelin (d18:0/16:0) levels compared with control group.
References
1 Integrative omics analysis of p53-dependent regulation of metabolism. FEBS Lett. 2018 Feb;592(3):380-393.
2 CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism. Sci Rep. 2020 Jun 17;10(1):9804.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.